Equity Details
Price & Market Data
Price: $0.788
Daily Change: -$0.0074 / 0.94%
Daily Range: $0.77 - $0.838
Market Cap: $10,189,374
Daily Volume: 195,601
Performance Metrics
1 Week: -2.57%
1 Month: -8.47%
3 Months: -84.97%
6 Months: -92.11%
1 Year: -94.88%
YTD: -85.75%
About Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Detailed insights into Reviva Pharmaceuticals Holdings, Inc. (RVPH)'s trading. Current price: 0.788, daily change: -$0.0074 / 0.94%. Market cap: 10,189,374. All long-term performance metrics, including 6-month and 1-year, are presented here.
Company Details
Employees: 14
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.